• (APS) Technical Patterns and Signals (APS:CA) news.stocktradersdaily.com Fri, 04 Jul 2025 07:34:38 GMT
• Aptose Biosciences Upgrades to OTCQB Market Listing The Globe and Mail Wed, 02 Jul 2025 12:46:00 GMT
• learn to evaluate (aps) using the charts (aps:ca) news.stocktradersdaily.com Tue, 01 Jul 2025 14:39:31 GMT
• Aptose Biosciences Defers Loan Interest Payments to Enhance Financial Flexibility TipRanks Mon, 30 Jun 2025 21:42:56 GMT
• Aptose Announces Deferral of Interest Payment | APTOF Stock News GuruFocus Mon, 30 Jun 2025 21:16:09 GMT
• aptose gains 6-month interest payment relief while advancing leukemia drug pipeline Stock Titan Mon, 30 Jun 2025 21:00:00 GMT
• Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year TipRanks Fri, 27 Jun 2025 12:54:58 GMT
• (APS) Investment Performance Report (APS:CA) news.stocktradersdaily.com Thu, 26 Jun 2025 03:56:14 GMT
• (aps) technical analysis and trading signals (aps:ca) news.stocktradersdaily.com Fri, 20 Jun 2025 17:18:05 GMT
• Aptose and Hanmi Enter New Loan Agreement to Advance Development GuruFocus Fri, 20 Jun 2025 07:00:00 GMT
• aptose ceo props up biotech’s finances to prevent company from going bust Fierce Biotech Tue, 17 Jun 2025 14:04:08 GMT
• Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty TipRanks Tue, 17 Jun 2025 12:12:20 GMT
• Aptose CEO props up biotech's finances to prevent company from going bust Fierce Biotech Tue, 17 Jun 2025 07:00:00 GMT
• (APS) Investment Analysis and Advice (APS:CA) news.stocktradersdaily.com Sun, 15 Jun 2025 06:36:52 GMT
• aptose biosciences reports promising results from tuscany trial in aml MSN Sat, 14 Jun 2025 06:47:10 GMT
• aptose presents safety, response, and mrd clinical data from tus GuruFocus Fri, 13 Jun 2025 02:24:02 GMT
• Aptose Biosciences Reports Promising Results from TUSCANY Trial in AML TipRanks Thu, 12 Jun 2025 16:41:55 GMT
• aptose presents safety, response, and mrd clinical data from tuscany phase 1/2 clinical trial of tuspetinib triplet therapy in new... The Manila Times Thu, 12 Jun 2025 16:18:48 GMT
• Aptose reports promising data from TUS+VEN+AZA therapy for AML Investing.com Thu, 12 Jun 2025 07:00:00 GMT
• where are the opportunities in (aps) (aps:ca) news.stocktradersdaily.com Mon, 09 Jun 2025 19:59:19 GMT
• (APS) Technical Pivots with Risk Controls (APS:CA) news.stocktradersdaily.com Wed, 04 Jun 2025 09:28:18 GMT
• (aps) pivots trading plans and risk controls (aps:ca) news.stocktradersdaily.com Sun, 01 Jun 2025 16:16:54 GMT
• Aptose's Closing of US$3M Investment by Hanmi Pharmaceutical McCarthy Tétrault Thu, 29 May 2025 08:53:19 GMT
• aptose biosciences completes public offering of common shares for us$74.2m McCarthy Tétrault Thu, 29 May 2025 08:35:22 GMT
• aptose biosciences closes public offering of us$21.3m in common shares McCarthy Tétrault LLP Thu, 29 May 2025 05:31:47 GMT
• Aptose Biosciences Inc. enters into exclusive license agreement with Hanmi Pharmaceutical McCarthy Tétrault Thu, 29 May 2025 04:43:08 GMT
• Aptose Biosciences Inc. Completes US$4.43M Registered Direct Offering and Concurrent Private Placement McCarthy Tétrault Thu, 29 May 2025 04:09:14 GMT
• aptose biosciences inc. announces it entered into a $25m committed equity facility McCarthy Tétrault Thu, 29 May 2025 03:22:27 GMT
• Aptose Biosciences Inc. enters into at-the-market sales agreement with Cantor Fitzgerald & Co. McCarthy Tétrault Thu, 29 May 2025 02:38:14 GMT
• Aptose Biosciences Inc. closes C$8M public offering McCarthy Tétrault Thu, 29 May 2025 01:12:12 GMT
• aptose enters equity distribution agreement with piper sandler and canaccord genuity McCarthy Tétrault Thu, 29 May 2025 01:06:58 GMT
• aptose announces results from annual and special meeting of shareholders The Manila Times Wed, 28 May 2025 07:00:00 GMT
• aptose biosciences approves key resolutions at shareholder meeting TipRanks Wed, 28 May 2025 07:00:00 GMT
• Aptose Announces Results from Annual and Special Meeting of Shareholders Yahoo Tue, 27 May 2025 21:53:00 GMT
• analyzing monte rosa therapeutics (nasdaq:glue) and aptose biosciences (nasdaq:apto) Defense World Tue, 27 May 2025 07:00:00 GMT
• trading (aps) with integrated risk controls (aps:ca) news.stocktradersdaily.com Tue, 27 May 2025 05:55:39 GMT
• aptose biosciences (nasdaq:apto) now covered by analysts at stocknews.com Defense World Thu, 22 May 2025 07:41:16 GMT
• (aps) investment performance report (aps:ca) news.stocktradersdaily.com Wed, 21 May 2025 19:54:18 GMT
• aptose announces dosing of first patient with 120 mg of tuspetinib in phase 1/2 tuscany trial of frontline triple drug therapy aft... The Manila Times Tue, 20 May 2025 11:45:47 GMT
• stocks in play: aptose biosciences inc. by baystreet.ca Investing.com Canada Tue, 20 May 2025 07:00:00 GMT
• aptose selected for prestigious oral presentation of data from tuscany phase 1/2 clinical trial of tuspetinib triplet therapy in n... Yahoo Wed, 14 May 2025 17:07:00 GMT
• stocknews.com begins coverage on aptose biosciences (nasdaq:apto) Defense World Wed, 14 May 2025 07:19:35 GMT
• trading (aps) with integrated risk controls (aps:ca) news.stocktradersdaily.com Sun, 11 May 2025 00:29:42 GMT
• (aps) market performance analysis (aps:ca) news.stocktradersdaily.com Thu, 08 May 2025 07:35:03 GMT
• aptose biosciences reports promising aml trial results and expands market presence TipRanks Thu, 08 May 2025 07:00:00 GMT
• in brief: positive new data for aptose’s triplet therapy in 1l aml insights.citeline.com Wed, 07 May 2025 07:00:00 GMT
• aptose biosciences (nasdaq:apto) coverage initiated at stocknews.com Defense World Tue, 06 May 2025 06:45:30 GMT
• (aps) technical patterns and signals (aps:ca) news.stocktradersdaily.com Mon, 05 May 2025 14:21:33 GMT
• stocks in play: aptose biosciences inc. by baystreet.ca Investing.com Canada Mon, 05 May 2025 14:05:02 GMT
• aptose biosciences reports promising results from tuscany trial for aml treatment TipRanks Mon, 05 May 2025 11:56:31 GMT
• breakthrough aml treatment: triple drug therapy shows complete remission in patients with resistant mutations Stock Titan Mon, 05 May 2025 07:00:00 GMT
• aptose provides clinical update for the tuspetinib-based triple drug frontline therapy in newly diagnosed aml patients from the ph... Yahoo Finance Mon, 05 May 2025 07:00:00 GMT
• comparing sana biotechnology (nasdaq:sana) & aptose biosciences (nasdaq:apto) Defense World Sun, 04 May 2025 07:00:00 GMT
• learn to evaluate (aps) using the charts (aps:ca) news.stocktradersdaily.com Fri, 02 May 2025 21:10:57 GMT
• stocknews.com initiates coverage on aptose biosciences (nasdaq:apto) Defense World Mon, 28 Apr 2025 09:09:31 GMT
• (aps) investment strategy and analysis (aps:ca) news.stocktradersdaily.com Thu, 24 Apr 2025 17:42:09 GMT
• Aptose Announces Auditor Not Standing for Re-Appointment The Manila Times Thu, 24 Apr 2025 07:00:00 GMT
• Major Red Flag: KPMG Abandons Aptose Over Complex Financial Instrument Controls Stock Titan Wed, 23 Apr 2025 07:00:00 GMT
• aptose to present at the 2025 bloom burton & co. healthcare investor conference Yahoo Finance Wed, 23 Apr 2025 07:00:00 GMT
• aptose reveals latest progress on revolutionary triple-drug therapy for untreated aml patients Stock Titan Wed, 23 Apr 2025 07:00:00 GMT
• aptose announces auditor not standing for re-appointment The Globe and Mail Wed, 23 Apr 2025 07:00:00 GMT
• aptose biosciences to present at 2025 bloom burton & co. healthcare investor conference Nasdaq Wed, 23 Apr 2025 07:00:00 GMT
• aptose biosciences announces change in accounting firm by investing.com Investing.com India Tue, 22 Apr 2025 07:00:00 GMT
• Aptose Biosciences announces change in accounting firm Investing.com Mon, 21 Apr 2025 07:00:00 GMT
• (aps) investment strategy and analysis (aps:ca) news.stocktradersdaily.com Mon, 21 Apr 2025 07:00:00 GMT
• aptose biosciences (nasdaq:apto) coverage initiated by analysts at stocknews.com Defense World Sun, 20 Apr 2025 07:00:00 GMT
• aptose biosciences (tse:aps) stock price passes below 200-day moving average – what’s next? The AM Reporter Thu, 17 Apr 2025 07:00:00 GMT
• objective long/short (aps) report (aps:ca) news.stocktradersdaily.com Sun, 13 Apr 2025 07:00:00 GMT
• aptose biosciences (nasdaq:apto) earns sell rating from analysts at stocknews.com Defense World Sat, 12 Apr 2025 05:42:46 GMT
• aptose biosciences advances aml therapy with promising results TipRanks Wed, 09 Apr 2025 03:52:02 GMT
• aptose biosciences advances aml therapy with promising results TipRanks Tue, 08 Apr 2025 07:00:00 GMT
• aptose biosciences (nasdaq:apto) now covered by stocknews.com Defense World Fri, 04 Apr 2025 07:00:00 GMT
• bitcoin defies tech rout as nasdaq suffers one of worst drops since 2000 The Globe and Mail Fri, 04 Apr 2025 07:00:00 GMT
• aptose biosciences shares to delist from nasdaq as of april 2 Yahoo Finance Wed, 02 Apr 2025 07:00:00 GMT
• ratios reveal: breaking down aptose biosciences inc (apto)’s financial health DWinneX Wed, 02 Apr 2025 07:00:00 GMT
• aptose biosciences to be delisted from nasdaq by investing.com Investing.com Canada Wed, 02 Apr 2025 03:57:29 GMT
• apto stock touches 52-week low at $1.86 amid sharp annual decline Investing.com Australia Tue, 01 Apr 2025 21:02:50 GMT
• nasdaq surges 1%; us construction spending rises in february Benzinga Tue, 01 Apr 2025 17:04:40 GMT
• dow dips over 400 points; ism manufacturing pmi falls in march Benzinga Tue, 01 Apr 2025 14:22:00 GMT
• Aptose Biosciences shares to delist from Nasdaq as of April 2 TipRanks Tue, 01 Apr 2025 13:14:11 GMT
• Aptose Faces Nasdaq Exit: What This Means for Investors and Trading Options Stock Titan Tue, 01 Apr 2025 07:00:00 GMT
• Aptose Common Shares to Delist from Nasdaq as of April 2, 2025 Yahoo Finance Tue, 01 Apr 2025 07:00:00 GMT
• Aptose Biosciences Says Shares to Be Delisted From Nasdaq MarketScreener Tue, 01 Apr 2025 07:00:00 GMT
• Aptose shares tumble following Nasdaq delisting decision Investing.com India Tue, 01 Apr 2025 07:00:00 GMT
• aptose biosciences to be delisted from nasdaq by investing.com Investing.com UK Tue, 01 Apr 2025 07:00:00 GMT
• h.c. wainwright raises aptose stock target to $6, maintains buy Investing.com Mon, 31 Mar 2025 07:00:00 GMT
• aptose biosciences price target raised to $6 from $2 at h.c. wainwright MSN Mon, 31 Mar 2025 00:53:01 GMT
• short interest in aptose biosciences inc. (nasdaq:apto) drops by 56.6% Defense World Sun, 30 Mar 2025 09:15:35 GMT
• hc wainwright forecasts strong price appreciation for aptose biosciences (nasdaq:apto) stock Defense World Sun, 30 Mar 2025 06:32:50 GMT
• aptose biosciences price target raised to $6 from $2 at h.c. wainwright Yahoo Finance Sat, 29 Mar 2025 07:00:00 GMT
• Aptose Biosciences Advances AML Therapy and Strengthens Financial Position TipRanks Fri, 28 Mar 2025 12:39:48 GMT
• aptose biosciences brief: adds results to date highlight tus potential as an "ideal" third drug to include in aml triplet therapy MarketScreener Fri, 28 Mar 2025 12:12:32 GMT
• aptose biosciences brief: signs debt conversion agreement with hanmi MarketScreener Fri, 28 Mar 2025 12:12:32 GMT
• better artificial intelligence (ai) stock: nvidia vs. amd The Globe and Mail Fri, 28 Mar 2025 12:00:19 GMT
• aptose achieves breakthrough in aml treatment while cutting losses by 50% in 2024 Stock Titan Fri, 28 Mar 2025 07:00:00 GMT
• aptose reports year end 2024 results and corporate highlights Yahoo Finance Fri, 28 Mar 2025 07:00:00 GMT
• aptose biosciences brief: says tuspetinib triple drug frontline therapy advancing in tuscany clinical trial marketscreener.com Fri, 28 Mar 2025 07:00:00 GMT
• aptose biosciences: stocks undervalued by analyst consensus on tsx (aps) The Globe and Mail Fri, 28 Mar 2025 07:00:00 GMT
• aptose biosciences reports fy24 eps ($36.38) vs. ($227.43) last year TipRanks Fri, 28 Mar 2025 07:00:00 GMT
• aptose biosciences price target raised to $6 from $2 at h.c. wainwright TipRanks Fri, 28 Mar 2025 07:00:00 GMT
• aptose biosciences: promising clinical progress and strategic collaborations justify buy rating TipRanks Fri, 28 Mar 2025 07:00:00 GMT
• aptose biosciences (nasdaq:apto) coverage initiated at stocknews.com Defense World Thu, 27 Mar 2025 09:35:14 GMT
• aptose biosciences (nasdaq:apto) now covered by stocknews.com The AM Reporter Thu, 27 Mar 2025 07:00:00 GMT
Aptose Biosciences Inc(NASDAQ:APTO) 
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refra...
Website: http://www.aptose.com
Founded: 2014
Full Time Employees: 31
Sector: Healthcare
Industry: Biotechnology